Atlas Trials

Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa

Clinical trial NCT02904902 · COMPLETED

Trial details

NCT number
NCT02904902
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2016-09-06
Primary completion
2017-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.